Breaking News Instant updates and real-time market news.

EW

Edwards Lifesciences

$225.10

3.18 (1.43%)

16:19
10/23/19
10/23
16:19
10/23/19
16:19

Edwards Lifesciences ups FY19 adjusted EPS view to $5.50-$5.65 from $5.20-$5.40

Consensus $5.34. For 2019, the company now expects total sales around the top of its previous $4.0B-$4.3B range, consensus $4.23B. "We are very pleased with our strong year-to-date performance. As patients and clinicians increasingly choose TAVR, we remain optimistic about the long-term growth opportunity. We are committed to aggressively investing in our future, consistent with our focused innovation strategy. We remain confident that the innovative therapies resulting from our investments will benefit a broader group of patients suffering from structural heart disease and continue to drive strong organic growth," said CEO Michael Mussallem.

  • 23

    Oct

  • 28

    Oct

EW Edwards Lifesciences
$225.10

3.18 (1.43%)

07/24/19
RAJA
07/24/19
NO CHANGE
Target $232
RAJA
Outperform
Edwards Lifesciences price target raised to $232 from $200 at Raymond James
Raymond James analyst Jayson Bedford raised his price target for Edwards Lifesciences to $232 from $200 on increased confidence given a sharp acceleration in TAVR growth and an earlier than expected approval for Low Risk. The analyst reiterates an Outperform rating on the shares.
09/23/19
PIPR
09/23/19
INITIATION
Target $240
PIPR
Overweight
Edwards Lifesciences initiated with an Overweight at Piper Jaffray
Piper Jaffray analyst Adam Maeder started Edwards Lifesciences with an Overweight rating and $240 price target. While the company trades at "multiple turns" above its large-cap peers, the stock can continue to work at current levels, Maeder tells investors in a research note. The analyst believes there is still upside to the "already high" Street expectations in the second half of 2019 and 2020. U.S. low-risk approval should give the broader transcatheter aortic valve replacement market "a shot in the arm," says Maeder.
10/14/19
FBCO
10/14/19
NO CHANGE
Target $261
FBCO
Outperform
Edwards Lifesciences price target raised to $261 from $226 at Credit Suisse
Credit Suisse analyst Matt Miksic raised his price target for Edwards Lifesciences to $261 from $226 as rising confidence in U.S. TAVR market drives stock and expectations higher. The analyst notes that the stock has "significantly" outperformed his universe over the past few months and year to date, driven by superiority of Low-Risk TAVR clinical trial results in March, and "very strong" performance of the company's U.S. TAVR business in Q2. Feedback on this market from clinicians remains positive, and Street estimates have creeped higher in recent weeks as a result, he adds. Miksic reiterates an Outperform rating on the shares.
10/22/19
RBCM
10/22/19
NO CHANGE
Target $250
RBCM
Outperform
Edwards Lifesciences price target raised to $250 from $217 at RBC Capital
RBC Capital analyst Brandon Henry raised his price target on Edwards Lifesciences to $250 and kept his Outperform rating going into its Q3 results. The analyst notes that the consensus forecast for U.S. transcatheter aortic valve replacement, or TAVR, is high with estimated growth rate in high teens, though the buy-side is estimating that rate to be over 20%. Henry adds that the company stands to benefit from the August FDA approval of SAPIEN 3 for low-risk patients and from its "landmark" Partner 3 results.

TODAY'S FREE FLY STORIES

ENR

Energizer

$48.35

6.34 (15.09%)

08:48
11/14/19
11/14
08:48
11/14/19
08:48
Recommendations
Energizer analyst commentary  »

Energizer price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

SNNA

Sienna Biopharmaceuticals

$0.16

-0.008 (-4.74%)

08:47
11/14/19
11/14
08:47
11/14/19
08:47
Hot Stocks
Sienna Biopharmaceuticals says Nasdaq panel grants request for continued listing »

Sienna Biopharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTNT

Fortinet

$99.69

-0.245 (-0.25%)

08:47
11/14/19
11/14
08:47
11/14/19
08:47
Conference/Events
Fortinet management to meet with MKM Partners »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 18

    Nov

  • 19

    Nov

  • 05

    Dec

  • 06

    Dec

  • 09

    Dec

  • 12

    Dec

PRSP

Perspecta

$27.79

-0.18 (-0.64%)

08:46
11/14/19
11/14
08:46
11/14/19
08:46
Hot Stocks
Perspecta Labs wins $6.6M award on DARPA GAPS program »

Perspecta announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRPT

Sarepta

$101.00

0.99 (0.99%)

08:45
11/14/19
11/14
08:45
11/14/19
08:45
Hot Stocks
Sarepta announces collaboration, license agreement with StrideBio »

arepta Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XNET

Xunlei

$5.79

0.07 (1.22%)

, AMC

AMC Entertainment

$8.77

-0.51 (-5.50%)

08:45
11/14/19
11/14
08:45
11/14/19
08:45
Options
Largest borrow rate increases among liquid names »

Latest data shows the…

XNET

Xunlei

$5.79

0.07 (1.22%)

AMC

AMC Entertainment

$8.77

-0.51 (-5.50%)

CGC

Canopy Growth

$18.52

-0.69 (-3.59%)

NLOK

NortonLifeLock

$24.57

0.36 (1.49%)

FB

Facebook

$193.20

-1.27 (-0.65%)

HGV

Hilton Grand Vacations

$35.24

-0.07 (-0.20%)

HEXO

Hexo

$1.99

-0.14 (-6.59%)

ADT

ADT Inc.

$8.36

0.66 (8.57%)

BUD

AB InBev

$79.37

0.28 (0.35%)

ABB

ABB

$21.93

0.11 (0.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 14

    Nov

  • 19

    Nov

  • 27

    Feb

UBER

Uber

$26.70

(0.00%)

08:43
11/14/19
11/14
08:43
11/14/19
08:43
Upgrade
Uber rating change  »

Uber upgraded to Buy from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 21

    Nov

  • 04

    Dec

WMT

Walmart

$121.06

1.93 (1.62%)

08:43
11/14/19
11/14
08:43
11/14/19
08:43
Recommendations
Walmart analyst commentary  »

Baird says positive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

PUFXF

Agraflora Organics

$0.00

(0.00%)

08:41
11/14/19
11/14
08:41
11/14/19
08:41
Hot Stocks
Agraflora Organics introduces organic lip balm SKU into 200 Gateway Newstands »

AgraFlora Organics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REED

Reed's

$0.72

0.0221 (3.17%)

08:41
11/14/19
11/14
08:41
11/14/19
08:41
Recommendations
Reed's analyst commentary  »

Reed's price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:40
11/14/19
11/14
08:40
11/14/19
08:40
General news
U.S. initial jobless claims jumped 14k to 225k in the week ended October 9 »

U.S. initial jobless…

08:40
11/14/19
11/14
08:40
11/14/19
08:40
General news
FX Action: The dollar »

FX Action: The dollar was…

FCN

FTI Consulting

$105.68

0.095 (0.09%)

08:39
11/14/19
11/14
08:39
11/14/19
08:39
Conference/Events
FTI Consulting management to meet with SunTrust »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

TIXC

Tix Corp

$0.00

(0.00%)

08:39
11/14/19
11/14
08:39
11/14/19
08:39
Earnings
Tix Corp reports Q3 EPS (6c) vs. (2c) last year »

Reports Q3 revenue $3.13M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTAP

NetApp

$60.04

-0.08 (-0.13%)

08:39
11/14/19
11/14
08:39
11/14/19
08:39
Recommendations
NetApp analyst commentary  »

NetApp price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 12

    Dec

ENPH

Enphase Energy

$18.93

-0.195 (-1.02%)

08:38
11/14/19
11/14
08:38
11/14/19
08:38
Hot Stocks
Enphase Energy says Vision Solar leverages products for customer experience »

Enphase Energy announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IMMP

Immutep

$1.77

-0.135 (-7.11%)

08:36
11/14/19
11/14
08:36
11/14/19
08:36
Hot Stocks
Immutep announces European patent grant for LAG525 antibody »

Immutep announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTSO

CytoSorbents

$4.44

0.05 (1.14%)

08:36
11/14/19
11/14
08:36
11/14/19
08:36
Conference/Events
CytoSorbents management to meet with B. Riley FBR »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

CCMP

Cabot Microelectronics

$156.67

0.28 (0.18%)

08:36
11/14/19
11/14
08:36
11/14/19
08:36
Downgrade
Cabot Microelectronics rating change  »

Cabot Microelectronics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

RMBL

RumbleON

$1.50

-0.83 (-35.62%)

08:35
11/14/19
11/14
08:35
11/14/19
08:35
Recommendations
RumbleON analyst commentary  »

RumbleON price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

LINC

Lincoln Educational

$1.90

(0.00%)

08:35
11/14/19
11/14
08:35
11/14/19
08:35
Earnings
Lincoln Educational sees FY19 revenue, student starts up 3%-5% »

Ex. Transitional segment.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 19

    Nov

  • 20

    Nov

08:35
11/14/19
11/14
08:35
11/14/19
08:35
General news
U.S. PPI rose 0.4% in October, with the core rate up 0.3% »

U.S. PPI rose 0.4% in…

LINC

Lincoln Educational

$1.90

(0.00%)

08:34
11/14/19
11/14
08:34
11/14/19
08:34
Earnings
Lincoln Educational reports Q3 EPS 5c, one est. 9c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 19

    Nov

  • 20

    Nov

AMPY

Amplify Energy

$6.22

-0.17 (-2.66%)

08:34
11/14/19
11/14
08:34
11/14/19
08:34
Initiation
Amplify Energy initiated  »

Amplify Energy initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:34
11/14/19
11/14
08:34
11/14/19
08:34
General news
Jobless Claims data reported »

Week of 11/9 Jobless…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.